Header cover image

South Korean (KOSPI) Biotech Industry Analysis

UpdatedJan 30, 2023
DataAggregated Company Financials
Companies102
  • 7D2.2%
  • 3M-4.3%
  • 1Y-21.8%
  • YTD3.3%

The Biotech industry is up 2.2% in the last week, with Celltrion up 2.6%. However, the industry is down 22% over the past year. Earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the South Korean Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 30 Jan 2023₩59.9t₩11.3t₩970.8b24.5x61.7x5.3x
Wed, 28 Dec 2022₩60.0t₩11.4t₩678.5b23.9x88.5x5.3x
Fri, 25 Nov 2022₩61.2t₩11.0t₩298.7b20.9x204.9x5.6x
Sun, 23 Oct 2022₩56.9t₩10.8t₩348.0b19.2x163.5x5.3x
Tue, 20 Sep 2022₩60.7t₩10.8t₩495.4b22.3x122.4x5.6x
Thu, 18 Aug 2022₩74.4t₩10.7t₩578.1b24.4x128.7x7x
Sat, 16 Jul 2022₩71.2t₩10.7t₩597.6b24.5x119.1x6.7x
Mon, 13 Jun 2022₩66.4t₩10.6t₩626.3b27.1x106x6.2x
Wed, 11 May 2022₩65.5t₩10.0t₩866.3b25x75.6x6.6x
Fri, 08 Apr 2022₩73.1t₩10.0t₩898.1b27.2x81.4x7.3x
Sun, 06 Mar 2022₩73.6t₩9.4t₩769.1b34.5x95.7x7.8x
Tue, 01 Feb 2022₩72.4t₩9.4t₩787.4b31.6x91.9x7.7x
Thu, 30 Dec 2021₩92.5t₩9.4t₩787.4b40.2x117.4x9.9x
Sat, 27 Nov 2021₩97.5t₩9.3t₩1.0t31.6x95.7x10.5x
Mon, 25 Oct 2021₩97.4t₩9.2t₩986.0b39.8x98.8x10.6x
Wed, 22 Sep 2021₩116.6t₩9.2t₩986.1b43.8x118.2x12.7x
Fri, 20 Aug 2021₩116.5t₩9.3t₩909.7b48.9x128.1x12.5x
Fri, 04 Jun 2021₩101.8t₩9.0t₩979.0b45.3x104x11.3x
Mon, 08 Mar 2021₩89.7t₩8.2t₩501.3b44.6x179x10.9x
Thu, 10 Dec 2020₩96.4t₩7.5t₩238.5b31.9x404.2x12.8x
Wed, 02 Sep 2020₩93.9t₩6.7t-₩13,176,736,074.0051.4x-7126.9x14x
Sat, 06 Jun 2020₩63.0t₩6.1t-₩304,564,934,452.0046.5x-206.9x10.4x
Tue, 10 Mar 2020₩46.6t₩5.8t-₩212,594,028,191.0049.2x-219.3x8x
Price to Earnings Ratio

-219.9x


Total Market Cap: ₩46.7tTotal Earnings: -₩212,594,028,191.00Total Revenue: ₩5.8tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Biotech Industry Price to Earnings3Y Average -464.4x202120222023
Current Industry PE
  • Investors are optimistic on the South Korean Biotechs industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 61.7x which is higher than its 3-year average PE of -464x.
  • The 3-year average PS ratio of 9.5x is higher than the industry's current PS ratio of 5.3x.
Past Earnings Growth
  • Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 25% per year.
  • This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market3.72%
Healthcare1.93%
Biotech2.17%
Biotech2.17%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A302440 SK bioscienceLtd₩77.00k3.6%
+₩207.3b
-53.3%PE21.2x
A068270 Celltrion₩163.70k0.7%
+₩172.0b
12.7%PE40.7x
A196170 ALTEOGEN₩35.10k3.2%
+₩56.7b
-12.3%PE438.4x
A086900 Medy-Tox₩134.20k4.8%
+₩37.9b
22.3%PE34.7x
A263050 Eutilex.Co.Ltd₩6.43k7.9%
+₩17.3b
-49.5%PS1756.2x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A302440

₩77,000.00

SK bioscienceLtd

7D

3.6%

1Y

-53.3%

A095700

₩14,200.00

Genexine

7D

-0.7%

1Y

-61.5%

A068270

₩163,700.00

Celltrion

7D

0.7%

1Y

12.7%

A214450

₩74,500.00

PharmaResearch

7D

-3.7%

1Y

-1.2%

A196170

₩35,100.00

ALTEOGEN

7D

3.2%

1Y

-12.3%

A086900

₩134,200.00

Medy-Tox

7D

4.8%

1Y

22.3%

A377740

₩8,630.00

BioNote

7D

-4.1%

1Y

n/a

A290650

₩21,700.00

L&C Bio

7D

-5.0%

1Y

-31.3%

A244460

₩5,250.00

OLIPASS

7D

-26.1%

1Y

-29.6%

A084990

₩11,520.00

Helixmith

7D

2.9%

1Y

-43.4%

A284620

₩5,850.00

Kainos Medicine

7D

9.8%

1Y

-39.7%

A011000

₩7,690.00

GeneOne Life Science

7D

-3.9%

1Y

-37.5%

A263050

₩6,430.00

Eutilex.Co.Ltd

7D

7.9%

1Y

-49.5%

A185490

₩6,510.00

EyeGene

7D

9.0%

1Y

-53.2%

A298380

₩19,260.00

ABL Bio

7D

-3.9%

1Y

-31.3%